JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Whitepaper
Chimeric Antigen Receptor (CAR) Natural Killer cells: a promising cell therapy strategy for cancer treatment
CAR Natural Killer cell therapy as a cancer treatment
Natural killer (NK) cell therapies use NK cells to detect and destroy target cells that cause disease, such as cancer cells. Modifying NK cells with Chimeric Antigen Receptors (CARs) offers a strategy for improving the clinical success of NK cell therapy.
Featured in this white paper:
- NK cell background and cytotoxicity
- CAR NK cell therapy description, including genetic modification and CAR generation
- Advantages, limitations, and clinical progress of CAR NK cell therapy
For research use only. Not for use in diagnostic procedures.
To view the full content please answer a few questions
Download Resource
Chimeric Antigen Receptor (CAR) Natural Killer cells: a promising cell therapy strategy for cancer treatment